Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Angeline Beltsos

Reproductive Endocrinology Chicago, IL Medical Doctor

NPI 1558404251 CMS profile 1282491

1455 N Milwaukee Ave Fl 2, Chicago, IL 60622

Open in the dashboard

General payments

$95,684

223 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Angeline Beltsos of Chicago, IL is reported in the CMS Open Payments database as having received $95,684 across 223 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Reproductive Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $427 9
2024 General $737 12
2023 General $46,257 40
2022 General $20,080 30
2021 General $7,499 37
2020 General $17,339 34
2019 General $3,346 61

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Angeline Beltsos
  • Reproductive Endocrinology median
  • Middle half of Reproductive Endocrinology
  • National median

In program year 2025, general payments to Angeline Beltsos were reported at $427. Among 986 Reproductive Endocrinology profiles paid that year, the median was $141 and the middle half received between $66 and $285.

Show as a table
Year Angeline Beltsos Reproductive Endocrinology median Middle half National median
2019 $3,346 $196 $77–$425 $163
2020 $17,339 $81 $35–$182 $114
2021 $7,499 $102 $43–$247 $132
2022 $20,080 $139 $62–$303 $149
2023 $46,257 $141 $65–$285 $160
2024 $737 $144 $65–$302 $164
2025 $427 $141 $66–$285 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ferring Pharmaceuticals Inc. $62,743 90 payments
  2. EMD Serono, Inc. $11,268 31 payments
  3. Ferring Pharmaceuticals Ltd (UK) $10,345 6 payments
  4. Merck Sharp & Dohme Corporation $4,991 34 payments
  5. Organon LLC $4,602 27 payments
  6. CooperSurgical, Inc. $1,329 15 payments
  7. Kedrion Biopharma Inc. $90 1 payment
  8. Avion Pharmaceuticals $88 6 payments
  9. Galen US Inc $49 3 payments
  10. Vertical Pharmaceuticals, LLC $34 2 payments
  11. Other $146 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $48,701 17 payments
  2. Consulting Fee $26,866 7 payments
  3. Travel and Lodging $12,680 26 payments
  4. Food and Beverage $7,438 173 payments
Products named General payments · program years 2019–2025
  1. MENOPUR Reproductive Health $57,571 57 payments
  2. Mavenclad $9,875 4 payments
  3. ENDOMETRIN $2,485 3 payments
  4. IVF Products Devices $800 8 payments
  5. Gonal-F $537 11 payments
  6. INVOCELL $453 11 payments
  7. MENOPUR Reproductive Health $448 7 payments
  8. FOLLISTIM AQ $421 26 payments
  9. PREGNYL $285 15 payments
  10. IVF Products Devices $279 3 payments
  11. Other $1,867 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

223 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Reproductive Endocrinology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record